• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Urinary incontinence Market

    ID: MRFR/HC/0591-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Urinary Incontinence Market Research Report By Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence, Mixed Incontinence), By Product (Absorbent Products, Surgical Products, Medications, Neuromodulation Devices, Catheters), By End-user (Hospitals, Nursing Homes, Home Care Settings, Ambulatory Surgical Centers), By Gender (Female, Male), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Urinary incontinence Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Urinary incontinence Market Summary

    As per Market Research Future Analysis, the Urinary Incontinence Market was valued at 3.27 USD Billion in 2024 and is projected to grow to 5.0 USD Billion by 2035, reflecting a CAGR of 3.93% from 2025 to 2035. The market is driven by increasing prevalence, advancements in treatment options, and rising awareness reducing stigma associated with urinary incontinence.

    Key Market Trends & Highlights

    The urinary incontinence market is experiencing significant trends driven by technology and awareness.

    • Market value in 2024: 3.27 USD Billion; projected to reach 5.0 USD Billion by 2035.
    • Stress Incontinence segment valued at 0.804 USD Billion in 2024; expected to rise to 1.292 USD Billion by 2035.
    • Urge Incontinence projected to grow from 0.919 USD Billion in 2024 to 1.458 USD Billion by 2035.
    • North America market value in 2024: 1.3 USD Billion; expected to grow to 2.0 USD Billion by 2035.

    Market Size & Forecast

    2023 Market Size USD 3.15 Billion
    2024 Market Size USD 3.27 Billion
    2035 Market Size USD 5.0 Billion
    CAGR (2025-2035) 3.93%

    Major Players

    Key Companies include SCA Hygiene Products, Hollister, Pfizer, Tena, Coloplast, Kimberly-Clark, Astellas Pharma, Johnson and Johnson, Stryker, C.R. Bard, ConvaTec, Novartis, Medtronic, Bayer AG, Boston Scientific.

    Urinary incontinence Market Trends

    Numerous significant market factors, chief among them demographic shifts including population aging and growing awareness of urine incontinence, impact the Urinary Incontinence Market. Urinary incontinence is becoming more common as the world's population ages, which increases the need for efficient treatment solutions.

    Furthermore, women's health concerns are receiving more attention, which encourages research into developing products especially for incontinent women. The emergence of technology-driven solutions, such as smart fabrics and wearable technologies, presents fresh chances to gain market share and creatively meet customer demands.

    Urinary incontinence conversations are becoming more accepted and normalized, according to recent trends, which lessens stigma and motivates people to get treatment. As a result, there are now more products available, ranging from surgical solutions to absorbent pads, giving customers additional options.

    More patient-centered care encourages the creation of tailored therapies, which is growing crucial in today's global marketplace. Additionally, there are new digital healthcare platforms that make it easier for patients to get help and services for incontinence.

    There are plenty of opportunities to improve the quality of life for people with urine incontinence by growing telehealth services and online counseling. Better product availability and reach are also made possible by the growth of e-commerce and online pharmacies.

    All things considered, the Urinary Incontinence Market is still changing as a result of growing consumer awareness, technological breakthroughs, and a trend in society toward candid discussions about health concerns.

    The increasing prevalence of urinary incontinence, driven by an aging population and rising awareness of treatment options, underscores the urgent need for innovative solutions in the healthcare sector.

    U.S. Department of Health and Human Services

    Urinary incontinence Market Drivers

    Market Growth Projections

    The Global Urinary Incontinence Market Industry is projected to experience robust growth in the coming years. By 2024, the market is expected to reach 3.27 USD Billion, with further growth anticipated to 5 USD Billion by 2035. This trajectory indicates a compound annual growth rate of 3.94 percent from 2025 to 2035. Such projections highlight the increasing demand for urinary incontinence solutions, driven by factors such as technological advancements, demographic shifts, and heightened awareness. The market's expansion reflects the urgent need for effective management strategies to address the challenges faced by individuals living with urinary incontinence.

    Growing Geriatric Population

    The global increase in the geriatric population is a significant factor influencing the Global Urinary Incontinence Market Industry. As individuals age, the likelihood of experiencing urinary incontinence rises due to physiological changes and comorbidities. According to demographic projections, the number of people aged 65 and older is expected to double by 2050, creating a larger market for urinary incontinence solutions. This demographic shift is likely to drive demand for various products, including absorbent pads, medications, and surgical interventions. Consequently, the market is poised for substantial growth as the needs of this aging population become more pronounced.

    Increased Awareness and Education

    Increased awareness and education regarding urinary incontinence are crucial drivers of the Global Urinary Incontinence Market Industry. Public health campaigns and educational initiatives are helping to destigmatize the condition, encouraging individuals to seek treatment. This shift in perception is vital, as many people suffer in silence due to embarrassment. As awareness grows, more individuals are likely to consult healthcare professionals, leading to higher demand for products and services. This trend is expected to contribute to a compound annual growth rate of 3.94 percent from 2025 to 2035, as more people recognize the importance of addressing urinary incontinence.

    Advancements in Treatment Technologies

    Technological advancements in treatment options for urinary incontinence are propelling the Global Urinary Incontinence Market Industry forward. Innovations such as minimally invasive surgical techniques, neuromodulation therapies, and advanced absorbent products are enhancing patient outcomes. For example, the introduction of new devices and surgical methods has improved efficacy and reduced recovery times. As a result, the market is projected to grow to 5 USD Billion by 2035, driven by these advancements. Furthermore, ongoing research and development efforts are likely to yield even more effective solutions, thereby expanding the market and improving quality of life for patients.

    Rising Prevalence of Urinary Incontinence

    The increasing prevalence of urinary incontinence among various demographics is a primary driver of the Global Urinary Incontinence Market Industry. Factors such as aging populations, obesity, and chronic conditions contribute to this rise. For instance, it is estimated that by 2024, the market will reach 3.27 USD Billion, reflecting the growing need for effective management solutions. The World Health Organization indicates that urinary incontinence affects a significant portion of older adults, with prevalence rates ranging from 15 to 30 percent. This trend underscores the urgency for innovative products and services tailored to address the needs of affected individuals.

    Regulatory Support and Reimbursement Policies

    Regulatory support and favorable reimbursement policies are essential drivers of the Global Urinary Incontinence Market Industry. Governments and health organizations are increasingly recognizing the need for effective management of urinary incontinence, leading to the establishment of supportive frameworks. For instance, many countries are implementing reimbursement policies that cover the costs of treatments and products for urinary incontinence. This support not only alleviates the financial burden on patients but also encourages manufacturers to innovate and expand their offerings. As a result, the market is likely to experience sustained growth, driven by these favorable conditions.

    Market Segment Insights

    Urinary Incontinence Market Type Insights 

    The Urinary Incontinence Market exhibited a diverse range of types that catered to various patient needs, with significant market valuations expected in the coming years. Within this market, the classifications included stress incontinence, urge incontinence, overflow incontinence, functional incontinence, and mixed incontinence.

    Stress Incontinence was a vital segment, anticipated to reach around 0.766 USD Billion in 2024, growing to 1.208 USD Billion by 2035, largely due to the increasing cases associated with activities that exerted pressure on the bladder, particularly among the aging population and women post-pregnancy.

    Similarly, Urge Incontinence, which held a valuation of 0.804 USD Billion in 2024, rising to 1.25 USD Billion by 2035, is largely driven by neurological disorders that impact bladder control, emphasizing the need for effective treatment options.

    Overflow Incontinence, while a smaller segment valued at 0.459 USD Billion in 2024 and expected to grow to 0.708 USD Billion by 2035, still represented a significant concern as it often resulted from urinary retention issues.

    On the other hand, Functional Incontinence, which is expected to increase from 0.536 USD Billion in 2024 to about 0.833 USD Billion in 2035, highlighted the market's responsiveness to conditions that limit a person's ability to reach the toilet in time, such as mobility issues.

    Urinary Incontinence Market Product Insights

    The market segment, focusing on products, sees various components playing crucial roles, especially in addressing the needs of individuals suffering from urinary incontinence. Absorbent products hold a significant share within the market, constituting the first line of defense for many users, offering comfort and reliability.

    Surgical products are also vital, providing long-term solutions for severe cases, thereby increasing their demand. Medications play an essential role by offering therapeutic options that manage symptoms effectively. Neuromodulation devices present innovative treatment approaches, focusing on altering nerve activity to improve bladder control.

    Catheters remain indispensable for those requiring assistance due to mobility issues or severe incontinence. The Urinary Incontinence Market data highlights that the unique combination of these product types creates diverse opportunities for growth, while also emphasizing the importance of research and development in creating new solutions.

    Overall, the segmentation of this market illustrates a multifaceted approach that effectively addresses the various needs of patients across the globe.

    Urinary Incontinence Market End-user Insights 

    Among these, hospitals play a crucial role, providing advanced treatments and technologies for managing urinary incontinence. Nursing homes serve the elderly population who frequently experience urinary complications, contributing significantly to market growth.

    Home care settings are increasingly preferred as they offer personalized care and convenience, appealing to individuals seeking privacy and comfort in managing their health. Ambulatory surgical centers have gained traction due to their cost-effectiveness and efficiency in treatment delivery.

    Together, these segments exhibit various growth drivers including increasing awareness about urinary incontinence, an aging population, and advances in healthcare technology. However, challenges such as the stigma associated with urinary incontinence persist.

    Overall, the Urinary Incontinence Market segmentation reflects a robust demand across these End-users, creating opportunities for innovative products and solutions to address the diverse needs of individuals affected by this condition.

    Urinary Incontinence Market Gender Insights

    The market is significantly influenced by gender dynamics, involving both male and female segments. Females traditionally represent the majority holding in the market due to higher prevalence rates of urinary incontinence conditions, particularly during pregnancy, childbirth, and menopause.

    The male segment is also gaining attention as awareness increases around male urinary issues, influenced by factors such as age and prostate health. The Urinary Incontinence Market growth is driven by rising geriatric populations, advancements in absorbent products, and increasing acceptance of incontinence products.

    However, challenges such as societal stigma and lack of awareness continue to impact market penetration. Furthermore, opportunities for innovation exist in developing targeted solutions for both genders, underscoring the importance of gender-specific products tailored to distinct needs.

    Overall, the statistics reveal a balanced yet diversified landscape that emphasizes the necessity of addressing urinary health concerns across genders in the Global market.

    Get more detailed insights about Urinary Incontinence Market Research Report-Forecast to 2035

    Regional Insights

    The Urinary Incontinence Market was segmented regionally, with significant variations in market valuations across different areas. In 2024, the market in North America was valued at 1.14 USD Billion, representing a major segment due to the high prevalence of incontinence and advanced healthcare infrastructure; this segment is expected to grow to 1.75 USD Billion by 2035.

    Europe followed closely, with a valuation of 1.03 USD Billion in 2024, driven by an aging population and increasing awareness, and is projected to reach 1.5 USD Billion by 2035. In South America, the market is valued at 0.25 USD Billion in 2024, reflecting potential growth opportunities, particularly in access to healthcare improvements, increasing to 0.4 USD Billion by 2035.

    The Asia Pacific region showed a promising outlook with a valuation of 0.81 USD Billion in 2024, influenced by rising medical expenditures and awareness, and is expected to ascend to 1.2 USD Billion by 2035. Finally, the Middle East and Africa showed a more modest valuation of 0.04 USD Billion in 2024, with challenges in healthcare access but potential for growth, reaching 0.15 USD Billion by 2035.

    This diverse geographical segmentation highlighted varying healthcare dynamics and emphasized the importance of developing tailored strategies to address regional needs in the Urinary Incontinence Market.

    Urinary Incontinence Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The competitive insights of the Urinary Incontinence Market reveal a dynamic landscape characterized by the presence of various players focusing on innovation, product development, and strategic partnerships.

    This market has gained significant traction due to the increasing prevalence of urinary incontinence issues among the aging population and the rising awareness regarding treatment options and management solutions. Companies in this sector are innovating their product lines to cater to diverse consumer needs while addressing concerns surrounding efficacy and user comfort.

    The competitive environment is shaped by factors such as technological advancements, regulatory changes, and evolving consumer expectations, leading to a continuous push for market participants to enhance their offerings and solidify their positions in the global arena.

    Coloplast stands out in the Urinary Incontinence Market with its robust portfolio of products designed to address various aspects of urinary incontinence management. The company's strengths lie in its commitment to innovation, with a strong focus on research and development that contributes to the creation of effective and user-friendly products.

    Coloplast's market presence is bolstered by its extensive distribution network and strong brand recognition, which enable it to reach a wide clientele. Additionally, its emphasis on customer feedback drives continuous improvement and customization of its product offerings, thus enhancing customer satisfaction and loyalty, which are pivotal for maintaining a competitive edge in the market.

    Essity, another key player in the Urinary Incontinence Market, showcases a comprehensive range of products tailored to manage urinary incontinence effectively. The company is known for its innovative absorbent hygiene products that resonate well within the global market niche.

    Strengths of Essity include its substantial research capabilities and commitment to sustainability, which align with today’s trends towards eco-friendly solutions. The company’s market presence is further enhanced by strategic mergers and acquisitions that broaden its reach and product line while maintaining a strong focus on quality.

    Essity’s dedication to improving user experience, combined with efforts in global marketing and sponsorship of various health initiatives, allows it to maintain a significant competitive presence in the market, helping millions of people manage their conditions more effectively.

    Key Companies in the Urinary incontinence Market market include

    Industry Developments

    An important advancement for a non-surgical, automated artificial urinary sphincter was marked on February 20th, 2025, when UroMems announced successful mid-term results from its first clinical feasibility study of the UroActive smart implant for treating stress urinary incontinence (SUI) in women. The results showed a reduction from 125 g to 4 g in a one-hour pad test.

    Medscape announced on April 28, 2025, that UroMems's UroActive device, which offers patients a less invasive and more convenient incontinence therapy, may be implanted robotically and managed remotely.

    Under the direction of urogynecologists at Stanford, NYU Langone, and Jefferson Health, Watkins-Conti Products concluded a multicenter clinical study of its Yōni.Fit vaginal insert for stress urine incontinence on April 20, 2023, in order to get ready to submit a 510(k) to the FDA.

    The U.S. CDC-funded National Association for Continence (NAFC) and Phreesia, Health.Equity, began a three-year awareness campaign on May 5, 2025.results, and Christina Escobar of NYU to de-stigmatize female incontinence and encourage early intervention.

    The PeriCoach, a home-based Kegel training tool with an app that improves pelvic-floor strengthening and patient compliance, was unveiled by Analytica Ltd. in October 2023. These achievements mark important breakthroughs in the treatment of urine incontinence worldwide on the clinical, technical, and educational fronts.

    Future Outlook

    Urinary incontinence Market Future Outlook

    The Global Urinary Incontinence Market is projected to grow at a 3.94% CAGR from 2024 to 2035, driven by increasing awareness, technological advancements, and an aging population.

    New opportunities lie in:

    • Develop innovative wearable devices for real-time monitoring of urinary health.
    • Expand telehealth services for remote consultations and management of urinary incontinence.
    • Invest in targeted marketing campaigns to raise awareness among underserved demographics.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment options and increased consumer engagement.

    Market Segmentation

    Urinary Incontinence Market Type Outlook

    • Stress Incontinence
    • Urge Incontinence
    • Overflow Incontinence
    • Functional Incontinence
    • Mixed Incontinence

    Urinary Incontinence Market Gender Outlook

    • Female
    • Male

    Urinary Incontinence Market Product Outlook

    • Absorbent Products
    • Surgical Products
    • Medications
    • Neuromodulation Devices
    • Catheters

    Urinary Incontinence Market End-user Outlook

    • Hospitals
    • Nursing Homes
    • Home Care Settings
    • Ambulatory Surgical Centers

    Urinary Incontinence Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Report Scope

    Report Attribute/Metric

    Details

    Market Size 2023

    3.15(USD Billion)

    Market Size 2024

    3.27(USD Billion)

    Market Size 2035

    5.0(USD Billion)

    Compound Annual Growth Rate (CAGR)

    3.94% (2025 - 2035)

    Report Coverage

    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

    Base Year

    2024

    Market Forecast Period

    2025 - 2035

    Historical Data

    2019 - 2024

    Market Forecast Units

    USD Billion

    Key Companies Profiled

    Coloplast, Essity, Stryker, Hollister, C.R. Bard, KimberlyClark, Ontex, Medtronic, Acelity, Convatec, Johnson & Johnson, Boston Scientific

    Segments Covered

    Type, Product, End-user, Gender, Regional

    Key Market Opportunities

    Rising geriatric population, Increasing awareness campaigns, Advancements in treatment technologies, Growing demand for homecare solutions, Expanding telehealth services

    Key Market Dynamics

    increasing aging population, growing awareness and acceptance, advancements in treatment options, favorable reimbursement policies, rising prevalence of obesity

    Countries Covered

    North America, Europe, APAC, South America, MEA

     

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What was the market size of the Urinary Incontinence Market in 2024?

    The Urinary Incontinence Market was valued at 3.27 billion USD in 2024.

    What will the market size be in 2035?

    By 2035, the Urinary Incontinence Market is projected to reach a value of around 5.0 billion USD.

    What is the expected CAGR for the Urinary Incontinence Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 3.94% between the years 2025 and 2035.

    Which region held the largest share in the Urinary Incontinence Market in 2024?

    In 2024, North America held the largest market share, valued at approximately 1.14 billion USD.

    What is the forecasted market size for Europe in 2035?

    The European segment of the Urinary Incontinence Market is expected to be valued at about 1.5 billion USD in 2035.

    The European segment of the Urinary Incontinence Market is expected to be valued at about 1.5 billion USD in 2035.

    Major players in the market include Coloplast, Essity, Stryker, and Johnson & Johnson, among others.

    What is the expected market size for Stress Incontinence by 2035?

    The market size for Stress Incontinence is anticipated to reach approximately 1.208 billion USD by 2035.

    Which region shows the highest growth potential for the Urinary Incontinence Market?

    The Asia Pacific region is expected to show significant growth with a market size of 1.2 billion USD anticipated in 2035.

    What was the market value for Urge Incontinence in 2024?

    Urge Incontinence held a market value of around 0.804 billion USD in 2024.

    What challenges does the Urinary Incontinence Market face?

    Challenges include the need for innovative treatment options and addressing the stigma associated with urinary incontinence.

    Urinary Incontinence Market Research Report-Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials